120 related articles for article (PubMed ID: 16301353)
1. Modulation of myocardial energetics: emerging evidence for a therapeutic target in cardiovascular disease.
Morrow DA; Givertz MM
Circulation; 2005 Nov; 112(21):3218-21. PubMed ID: 16301353
[No Abstract] [Full Text] [Related]
2. [Ischemic heart disease and heart failure. State of the art--new developments].
Kochsiek K
Fortschr Med; 1991 Apr; 109(10):217-8. PubMed ID: 2071077
[No Abstract] [Full Text] [Related]
3. [Cardiac energetics and coronary circulation].
Noguchi T; Goto Y
Nihon Rinsho; 2003 Apr; 61 Suppl 4():47-55. PubMed ID: 12734952
[No Abstract] [Full Text] [Related]
4. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
Butter C; Wellnhofer E; Schlegl M; Winbeck G; Fleck E; Sabbah HN
J Card Fail; 2007 Mar; 13(2):137-42. PubMed ID: 17395055
[TBL] [Abstract][Full Text] [Related]
5. [Modelling of acute heart failure: electrode monitoring of myocardial metabolism and the implantation of an artificial heart ventricle].
Ioseliani GD; Chilaia SM; Khodeli NG
Vestn Akad Med Nauk SSSR; 1987; (11):76-80. PubMed ID: 3445689
[No Abstract] [Full Text] [Related]
6. [Changes in the functional status of the myocardium after left ventricular bypass].
Gutnikova AR; Babakhanova VB; Kamalova GA; Leshchenko NA; Kasymov AKh
Kardiologiia; 1984 Jan; 24(1):93-4. PubMed ID: 6700144
[No Abstract] [Full Text] [Related]
7. Impaired energetics in heart failure - a new therapeutic target.
Ormerod JO; Ashrafian H; Frenneaux MP
Pharmacol Ther; 2008 Sep; 119(3):264-74. PubMed ID: 18602947
[TBL] [Abstract][Full Text] [Related]
8. [Energetics and ventricular work in relation to coronary circulation].
Federici A
Cardiologia; 1987 Nov; 32(11):1355-8. PubMed ID: 3329007
[No Abstract] [Full Text] [Related]
9. The time for a new strong functional parameter in heart failure: the VE/VCO2 slope.
Jaussaud J; Aimable L; Douard H
Int J Cardiol; 2011 Mar; 147(2):189-90. PubMed ID: 21106265
[No Abstract] [Full Text] [Related]
10. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H; Kinugawa S; Matsushima S
Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
[TBL] [Abstract][Full Text] [Related]
12. Relationship between coronary resistance, a redox potential across the heart and myocardial consumption of lactate and oxygen.
Marchetti G; Merlo L; Brusoni B
Biochem Exp Biol; 1977; 13(3):267-75. PubMed ID: 16296008
[No Abstract] [Full Text] [Related]
13. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
Lopaschuk GD
Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):228-30. PubMed ID: 16959756
[TBL] [Abstract][Full Text] [Related]
14. Metabolic modulation: a means to mend a broken heart.
Lopaschuk GD; Rebeyka IM; Allard MF
Circulation; 2002 Jan; 105(2):140-2. PubMed ID: 11790689
[No Abstract] [Full Text] [Related]
15. Myocardial metabolism in old age with particular reference to coronary artery disease.
Bing J; Leb G; Gudbjarnson S
G Gerontol; 1969 Oct; 17(10):961-72. PubMed ID: 5374674
[No Abstract] [Full Text] [Related]
16. [Oxygen: from transport to consumption. Symposium organized by Lilly-France Laboratory, Paris, September 22, 1989].
Teboul JL
Rev Prat; 1990 Sep; 40(19):1777-9. PubMed ID: 2218338
[No Abstract] [Full Text] [Related]
17. The failing heart.
Taegtmeyer H
N Engl J Med; 2007 Jun; 356(24):2545-6; author reply 2546. PubMed ID: 17575596
[No Abstract] [Full Text] [Related]
18. When the heart sleeps... is the vagus resetting the myocardial 'redox clock'?
Vecoli C; Paolocci N
Cardiovasc Res; 2008 Mar; 77(4):609-11. PubMed ID: 18194992
[No Abstract] [Full Text] [Related]
19. [What are the critical limits of hemodilution--cardiovascular aspects].
Klövekorn WP
Beitr Infusionsther; 1993; 29():70-80. PubMed ID: 7690663
[No Abstract] [Full Text] [Related]
20. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.
Byrne MJ; Power JM; Preovolos A; Mariani JA; Hajjar RJ; Kaye DM
Gene Ther; 2008 Dec; 15(23):1550-7. PubMed ID: 18650850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
